Apex Healthcare versus Dutch Lady (A Comparative Study)
| 3.4.2012 | | 5.3.2012 |
| Apex Healthcare | Dutch Lady |
| | | |
| | | |
| Income Statement | | | |
| 31/12/2011 | 31/12/2011 |
| RM (m) | | RM (m) |
| Revenue | 366.00 | | 810.65 |
| Gross Profit | 95.14 | | 304.47 |
| Operating Profit | - | | 139.372 |
| Financing costs | -0.288 | | -0.919 |
| PBT | 35.849 | | 141.553 |
| PAT | 28.468 | | 108.082 |
| | | |
| EPS (basic) sen | 29.96 | | 168.88 |
| EPS (diluted) sen | 29.96 | | |
| | | |
| | | |
| | | |
| Balance Sheet | | | |
| NCA | 85.596 | | 74.048 |
| CA | 202.303 | | 324.465 |
| Total Assets | 287.899 | | 398.513 |
| | | |
| Total Equity | 212.212 | | 259.154 |
| NCL | 8.737 | | 4.051 |
| CL | 66.95 | | 135.308 |
| Total Liabilities | 75.687 | | 139.359 |
| Total Eq + Liab | 287.899 | | 398.513 |
| | | |
| Net assets per share | 2.120 | | 4.05 |
| | | |
| | | |
| Cash & Eq | 22.802 | | 193.143 |
| LT Borrowings | 1.345 | | 0 |
| ST Borrowings | 2.267 | | 0 |
| Net Cash | 19.19 | | 193.143 |
| | | |
| | | |
| Inventories | 43.098 | | 93.448 |
| Trade receivables | 86.158 | | 36.713 |
| Trade payables | 63.665 | | 121.831 |
| | | |
| | | |
| Quick Ratio | 2.38 | | 1.71 |
| Current Ratio | 3.02 | | 2.40 |
| | | |
| | | |
| | | |
| Cash flow statement | | | |
| PBT | 35.849 | | 141.553 |
| OPBCWC | 42.941 | | |
| Cash from Operations | 39.476 | | 188.290 |
| Net CFO | 32.650 | | 161.940 |
| CFI | -15.866 | | -7.135 |
| CFF | -16.979 | | -47.319 |
| | | |
| | | |
| Capex | -13.251 | | -10.882 |
| FCF | 19.399 | | 151.058 |
| | | |
| Dividends paid | -11.363 | | -46.400 |
| DPS (sen) | 12.12 | | 72.5 |
| | | |
| No of ord shares (m) | | | |
| basic | 93.717 | | 64 |
| diluted | | | |
| | | |
| | | |
| Financial Ratios | | | |
| | | |
| Gross Profit Margin | 25.99% | | 37.56% |
| Net Profit Margin | 7.78% | | 13.33% |
| Asset Turnover | 1.27 | | 2.03 |
| Financial Leverage | 1.36 | | 1.54 |
| | | |
| | | |
| ROA | 9.89% | | 27.12% |
| ROC | 14.75% | | 163.73% |
| ROE | 13.41% | | 41.71% |
| | | |
| | | |
| Valuation | 3.4.2012 | | 5.3.2012 |
| | | |
| Price | 2.92 | | 29.5 |
| Market cap (m) | 273.65 | | 1888.00 |
| | | |
| P/E | 9.61 | | 17.47 |
| P/BV | 1.29 | | 7.29 |
| P/FCF | 14.11 | | 12.50 |
| P/Div | 24.08 | | 40.69 |
| | | |
| DPO ratio | 0.40 | | 0.43 |
| | | |
| EY | 10.40% | | 5.72% |
| FCF/P | 7.09% | | 8.00% |
| DY | 4.15% | | 2.46% |
| | | |
